![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
2MB |
![[thumbnail of Supplementary Material]](https://edoc.mdc-berlin.de/style/images/fileicons/other.png) |
Other (Supplementary Material)
778kB |
| Item Type: | Review |
|---|---|
| Title: | Brain volumetry and spinal cord imaging in patients with AQP4-IgG+ NMOSD - a systematic review and meta-analysis |
| Creators Name: | Heine, Josephine and Chien, Claudia |
| Abstract: | BACKGROUND: Magnetic resonance imaging (MRI) is often used to evaluate disease-related brain changes in patients with aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (AQP4-IgG+ NMOSD). OBJECTIVES: To use a meta-analysis for assessment of quantitative volumetric brain and spinal cord changes in patients with AQP4-IgG+ NMOSD and healthy participants. DESIGN: We analyzed volume estimates of the brain, gray matter, white matter, thalamus, T2/FLAIR-brain lesions, as well as mean upper cervical cord area (MUCCA). Inclusion criteria included patients with AQP4-IgG+ NMOSD, MRI-based segmentation data, and matched healthy participants. Data from NMOSD patients with mixed/unknown serostatus or significant comorbidities were excluded. DATA SOURCES: We searched MEDLINE through Pubmed for peer-reviewed articles published between 05/2006 (revised NMOSD diagnostic criteria) and 01/2025. METHODS: Standardized mean differences and pooled effect sizes (Hedges’ g) were determined with random-effects models, adjusting for duplicate reporting, outliers, and small study effects. Metaregressions were used to determine clinical associations. RESULTS: Evidence of pooled data showed that whole brain volume (g = -0.61, 95% confidence interval (CI): -0.91 to -0.32, p < 0.001, N(pat/con) = 385/325, k = 11) and gray matter volume (g = -0.40, 95% CI: -0.72 to -0.09, p = 0.018, N(pat/con) = 259/267, k = 9) were significantly different between patients and healthy participants. Heterogeneity was moderate (τ(2) = 0.08 and τ(2) = 0.09, respectively). Moreover, we found a large effect for reduced MUCCA (g = -0.99, 95% CI: -1.59 to -0.39, p = 0.007, N(pat/con) = 189/162, k = 7) with moderate heterogeneity (τ(2) = 0.31). No conclusive evidence emerged for changes in thalamic or white matter volume. Bias analysis did not indicate that smaller studies affected effect sizes. A systematic review of voxel-based morphometry revealed that reduced gray matter volume was most likely in the bilateral thalamus (⩽69%) and occipital (44%), frontal (27%), and temporal cortices (27%). CONCLUSION: AQP4-IgG+ NMOSD patients have specific global and local central nervous system volume reductions, potentially induced by astrocytic damage and demyelination. Volumetric outcomes may therefore inform MRI-guided disease monitoring and endpoints in clinical studies. TRIAL REGISTRATION: PROSPERO (CRD42024493121). This study follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting guidelines. |
| Keywords: | Aquaporin-4, Deep Gray Matter, Lesion Volume, Magnetic Resonance Imaging, MUCCA, Neuromyelitis Optica Spectrum Disorder, Segmentation, Thalamus, Volumetry, Voxel-Based Morphometry |
| Source: | Therapeutic Advances in Neurological Disorders |
| ISSN: | 1756-2856 |
| Publisher: | Sage Publications |
| Volume: | 18 |
| Page Range: | 1-22 |
| Date: | December 2025 |
| Official Publication: | https://doi.org/10.1177/17562864251394843 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
